div class=trans-pagebuttonPage 1button div class=trans-image a href=https:reader039fdokumencomreader039viewer202305152163452089df19c083b107eb5ehtml5page1webp target=_blank amp-img class=trans-thumb alt=Page 1: A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease src=https:reader039fdokumencomreader039viewer202305152163452089df19c083b107eb5ehtml5thumbnails1webp width=142 height=106 layout=responsive amp-imga divdivdiv class=trans-pagebuttonPage 2button div class=trans-image a href=https:reader039fdokumencomreader039viewer202305152163452089df19c083b107eb5ehtml5page2webp target=_blank amp-img class=trans-thumb alt=Page 2: A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease src=https:reader039fdokumencomreader039viewer202305152163452089df19c083b107eb5ehtml5thumbnails2webp width=142 height=106 layout=responsive amp-imga divdivdiv class=trans-pagebuttonPage 3button div class=trans-image a href=https:reader039fdokumencomreader039viewer202305152163452089df19c083b107eb5ehtml5page3webp target=_blank amp-img class=trans-thumb alt=Page 3: A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease src=https:reader039fdokumencomreader039viewer202305152163452089df19c083b107eb5ehtml5thumbnails3webp width=142 height=106 layout=responsive amp-imga divdivdiv class=trans-pagebuttonPage 4button div class=trans-image a href=https:reader039fdokumencomreader039viewer202305152163452089df19c083b107eb5ehtml5page4webp target=_blank amp-img class=trans-thumb alt=Page 4: A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease src=https:reader039fdokumencomreader039viewer202305152163452089df19c083b107eb5ehtml5thumbnails4webp width=142 height=106 layout=responsive amp-imga divdivdiv class=trans-pagebuttonPage 5button div class=trans-image a href=https:reader039fdokumencomreader039viewer202305152163452089df19c083b107eb5ehtml5page5webp target=_blank amp-img class=trans-thumb alt=Page 5: A Trial of Darbepoetin Alfa in Type 2...